{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:05:53Z","timestamp":1776762353163,"version":"3.51.2"},"reference-count":24,"publisher":"Scientific Scholar","content-domain":{"domain":["nmji.in"],"crossmark-restriction":true},"short-container-title":["NMJI"],"abstract":"\n Background<\/jats:title>\n Cardiac sarcoidosis (CS) may present with conduction abnormalities, ventricular arrhythmias, and heart failure. The delay in recognizing cardiac involvement in systemic sarcoidosis leads to disease progression, resulting in major morbidity and mortality. We studied the clinical, electrocardiographic, and imaging features of cardiac sarcoidosis and its mortality predictors.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The clinical data of patients with CS who presented to the Sree Chitra Tirunal Institute for Medical Sciences and Technology between 2005 and 2021 were retrospectively analysed. The diagnosis of CS was based on the 2014 Heart Rhythm Society Expert Consensus recommendations and the 2016 Japanese Circulation Society clinical diagnosis criteria. Patients with obstructive coronary artery disease and possible myocarditis were excluded from the study.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Forty-three patients of CS (31 males), aged 49 (8.8) years, were followed up for a mean duration of 4.3 (range 1.87\u20136.5) years. The presenting clinical manifestations were ventricular tachycardia (VT) 14\/43 (33%), acute heart failure 14\/43 (33%), complete heart block 10\/43 (23%), and non-sustained VT\/symptomatic ventricular premature complexes 2\/43 (5%). Systemic manifestations included lymphadenopathy 28\/43 (65%), pulmonary parenchymal involvement 26\/43 (60%), and neurological involvement 8\/43 (19%). The mean basal left ventricular ejection fraction at presentation was 41.1% (standard deviation 16.1%), and 31\/33 (94%) of the patients had late gadolinium enhance-ment in cardiac MRI, with the predominant pattern being sub-epicardial 18\/33 (58%) or mid-myocardial 17\/33 (54%). Eighteen (42%) patients received implantable cardioverter defibrillator (ICD); nearly half had appropriate ICD shocks. On follow-up, 11 (25%) patients died, 10 (23%) had recurrent heart failure admissions, and 5 (29%) had recurrent ICD shocks. Multivariate analysis revealed higher New York Heart Association (NYHA) class\/clinical heart failure at presentation, elevated erythrocyte sedimentation rate at diagnosis, and persistent low ejection fraction during follow-up to be predictors of mortality, not VT. Survival analysis showed that recurrent heart failure admissions predict early mortality.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Although arrhythmia was the most common manifestation, clinical heart failure was seen in nearly half of the patients with a diagnosis of CS. A high prevalence of heart failure, along with 25% mortality in our study, may indicate a delayed recognition of cardiac involvement in these patients\u2019 natural history. Recurrent heart failure admissions predicted early mortality.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/nmji_487_2023","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:31:40Z","timestamp":1776760300000},"page":"154-158","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical profile and mortality predictors in cardiac sarcoidosis: A single centre observational study"],"prefix":"10.25259","volume":"39","author":[{"given":"SUGATHAN","family":"VISHNU","sequence":"first","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NARAYANAN","family":"NAMBOODIRI","sequence":"additional","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MUKUND","family":"PRABHU","sequence":"additional","affiliation":[{"name":"Department of Cardiology,Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANOOP","family":"AYYAPPAN","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINEESH","family":"VALAKKADA","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SRINIVASA","family":"PRASAD B.V.","sequence":"additional","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KRISHNA KUMAR","family":"MOHANAN NAIR","sequence":"additional","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ABHILASH","family":"PUSHPANGADAN","sequence":"additional","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AJITKUMAR","family":"VALAPARAMBIL","sequence":"additional","affiliation":[{"name":"Department of Imaging Sciences and Interventional Radiology,Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"10.25259\/NMJI_487_2023\/ref-1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinico-pathological study on fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.25259\/NMJI_487_2023\/ref-2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/20009666.2020.1796053","article-title":"Challenges in diagnosing cardiac sarcoidosis: Should we increase our index of suspicion?","volume":"10","author":"Tagliaferri","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.25259\/NMJI_487_2023\/ref-3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"10.25259\/NMJI_487_2023\/ref-4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart","volume":"83","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.25259\/NMJI_487_2023\/ref-5","doi-asserted-by":"publisher","first-page":"e18037","DOI":"10.1097\/MD.0000000000018037","article-title":"Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study","volume":"98","author":"Martusewicz-Boros","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.25259\/NMJI_487_2023\/ref-6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.25259\/NMJI_487_2023\/ref-7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.25259\/NMJI_487_2023\/ref-8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00408-015-9805-8","article-title":"Cardiac sarcoidosis: is it more common in men?","volume":"194","author":"Martusewicz-Boros","year":"2016","journal-title":"Lung"},{"key":"10.25259\/NMJI_487_2023\/ref-9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/heartjnl-2021-319129","article-title":"Risk and predictors of heart failure in sarcoidosis: A population-based cohort study from Sweden","volume":"108","author":"Rossides","year":"2022","journal-title":"Heart"},{"key":"10.25259\/NMJI_487_2023\/ref-10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: A comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.25259\/NMJI_487_2023\/ref-11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jjcc.2020.07.006","article-title":"The ECG in sarcoidosis-A marker of cardiac involvement? Current evidence and clinical implications","volume":"77","author":"Willy","year":"2021","journal-title":"J Cardiol"},{"key":"10.25259\/NMJI_487_2023\/ref-12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ihj.2015.03.012","article-title":"fQRS as a marker of granulomatous disease in patients with ventricular tachycardia and normal ejection fraction","volume":"67","author":"Roukoz","year":"2015","journal-title":"Indian Heart J"},{"key":"10.25259\/NMJI_487_2023\/ref-13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1542-474X.2009.00320.x","article-title":"Fragmented QRS on 12-lead ECG: A marker of cardiac sarcoidosis as detected by gadolinium CMR","volume":"14","author":"Homsi","year":"2009","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.25259\/NMJI_487_2023\/ref-14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jjcc.2020.07.006","article-title":"The ECG in sarcoidosis-A marker of cardiac involvement?","volume":"77","author":"Willy","year":"2021","journal-title":"J Cardiol"},{"key":"10.25259\/NMJI_487_2023\/ref-15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.25259\/NMJI_487_2023\/ref-16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late gadolinium enhancement in cardiac sarcoidosis: Characteristic MRI findings and relationship with LV function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J Thorac Imaging"},{"key":"10.25259\/NMJI_487_2023\/ref-17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter-defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.25259\/NMJI_487_2023\/ref-18","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.25259\/NMJI_487_2023\/ref-19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1046\/j.1540-8167.2003.01554.x","article-title":"Analysis of ICD therapy in the antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"14","author":"Klein","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.25259\/NMJI_487_2023\/ref-20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.CIR.0000121738.88273.43","article-title":"ICD therapy in arrhythmogenic right ventricular cardiomyopathy: Long-term outcomes and complications in 60 patients","volume":"109","author":"Wichter","year":"2004","journal-title":"Circulation"},{"key":"10.25259\/NMJI_487_2023\/ref-21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.25259\/NMJI_487_2023\/ref-22","doi-asserted-by":"publisher","first-page":"e021183","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: A systematic review","volume":"10","author":"Fazelpour","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.25259\/NMJI_487_2023\/ref-23","first-page":"17","article-title":"Factors associated with appropriate ICD therapy in cardiac sarcoidosis: A meta-analysis","volume":"37","author":"Azoulay","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.25259\/NMJI_487_2023\/ref-24","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1016\/j.jacc.2016.05.011","article-title":"2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: Update of the 2013 guideline","volume":"134","author":"Yancy","year":"2016","journal-title":"Circulation"}],"container-title":["The National Medical Journal of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/nmji.in\/clinical-profile-and-mortality-predictors-in-cardiac-sarcoidosis-a-single-centre-observational-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nmji.in\/clinical-profile-and-mortality-predictors-in-cardiac-sarcoidosis-a-single-centre-observational-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:31:41Z","timestamp":1776760301000},"score":1,"resource":{"primary":{"URL":"https:\/\/nmji.in\/clinical-profile-and-mortality-predictors-in-cardiac-sarcoidosis-a-single-centre-observational-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":24,"alternative-id":["10.25259\/NMJI_487_2023"],"URL":"https:\/\/doi.org\/10.25259\/nmji_487_2023","relation":{},"ISSN":["2583-150X","0970-258X"],"issn-type":[{"value":"2583-150X","type":"electronic"},{"value":"0970-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"154"}}